Onconetix, Inc. Files 8-K on Material Agreement
Ticker: ONCO · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1782107
Sentiment: neutral
Topics: material-agreement, financial-obligation, corporate-update
TL;DR
Onconetix just filed an 8-K for a material agreement and financial obligation. Big moves ahead.
AI Summary
Onconetix, Inc. filed an 8-K on June 11, 2025, reporting a material definitive agreement and a direct financial obligation. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio.
Why It Matters
This filing indicates significant new contractual commitments or financial obligations for Onconetix, Inc., which could impact its financial health and strategic direction.
Risk Assessment
Risk Level: medium — The filing indicates new financial obligations and material agreements, which carry inherent risks related to execution and financial impact.
Key Players & Entities
- Onconetix, Inc. (company) — Registrant
- Blue Water Biotech, Inc. (company) — Former company name
- Blue Water Vaccines Inc. (company) — Former company name
- June 11, 2025 (date) — Date of report
FAQ
What is the nature of the material definitive agreement Onconetix, Inc. entered into?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
What is the direct financial obligation being reported by Onconetix, Inc.?
The filing indicates the creation of a direct financial obligation but does not provide specific details about its nature or amount.
When was the report filed and what is the earliest event date?
The report was filed on June 11, 2025, and the earliest event reported is also June 11, 2025.
What were Onconetix, Inc.'s previous company names?
Onconetix, Inc. was formerly known as Blue Water Biotech, Inc. (name change on April 24, 2023) and Blue Water Vaccines Inc. (name change on July 10, 2019).
Where is Onconetix, Inc. headquartered?
Onconetix, Inc. is headquartered in Cincinnati, Ohio, with its business address at 201 E. Fifth Street, Suite 1900.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Onconetix, Inc. (ONCO).